Small Cap U.S. Stocks with Positive and Negative Sentiment on July 8, 2023
On July 8, 2023, a number of small cap U.S. stocks appeared in news headlines, with some having a positive sentiment and others having a negative sentiment.
Positive Sentiment
- Prometheus Biosciences (PRPH): Prometheus Biosciences is developing a new drug for the treatment of cancer. This could be a major breakthrough for the company, and could lead to increased demand for its shares.
- TG Therapeutics (TGTX): TG Therapeutics is developing a new drug for the treatment of cancer. This could be a major breakthrough for the company, and could lead to increased demand for its shares.
- Aero Therapeutics (ATRO): Aero Therapeutics is developing a new drug for the treatment of asthma. This could be a major breakthrough for the company, and could lead to increased demand for its shares.
Negative Sentiment
- CTI BioPharma (CTIB): CTI BioPharma is being acquired by Swedish Orphan Biovitrum AB (SOBI) for $9.10 per share. This could lead to decreased demand for CTI BioPharma’s shares, as investors may believe that the acquisition is undervalued.
- Applied Digital (APLD): Applied Digital is facing a lawsuit from the U.S. Securities and Exchange Commission (SEC). This could lead to decreased demand for Applied Digital’s shares, as investors may be concerned about the company’s legal troubles.
- Mirati Therapeutics (MRTX): Mirati Therapeutics is facing delays in the development of its cancer drugs. This could lead to decreased demand for Mirati Therapeutics’ shares, as investors may be concerned about the company’s ability to bring its drugs to market.
It is important to note that these are just a few of the many small cap U.S. stocks that appeared in news headlines on July 8, 2023. The sentiment of the news articles could change over time, and the actual impact on stock prices could vary.
Title: Small Cap U.S. Stocks with Positive and Negative Sentiment on July 8, 2023